SubjectWell

Instead of a “one-size-fits-all” strategy, oncologists are increasingly approaching treatment on a case-by-case basis. Similarly, clinical trials in precision oncology aim to improve patient experience and outcomes by matching therapies to fit factors on the molecular level. More on these advancements on our blog: https://ow.ly/KZCg50ROXlp #breastcancer #breastcancerawarenessmonth #lifesciences #clinicalresearch

Oh, what a week!?? Last week, nearly 100 of us gathered in a small town outside of Austin, TX, traveling from all corners of the world ?? for?Collide 2024. We came together with a shared belief: great things happen when people and ideas collide. At this intersection, innovation takes shape, diverse perspectives ignite creativity, and solutions to the most complex challenges in clinical and commercial development are realized. These collisions generate the kind of energy that drives change—not just for our customers but most importantly, for patients. ???? Collide 2024?inspired us to be better and?to strive for more so that we can improve global healthcare in ways we dare to imagine! ?? #patientrecruitment #patientengagement #globalhelathcare

??♂??Giving Back, One Bike at a Time!???♀? At SubjectWell, we're passionate about supporting our local communities through our?SubjectWell Wishes?program. During?Collide 2024, our annual strategy retreat, our team came together to build bikes for the Marble Falls, TX?Operation Blue Santa! ??? While team bonding is always fun, the true joy comes from knowing we’re making a difference and putting smiles on the faces of some amazing kids. ?? And yes, we may have “tested” a few of them out, too. ???? Here’s to more moments that matter and the chance to give back in both big and small ways! #GivingBack #Community #WellWishes #Collide2024 #OperationBlueSanta

Not one, not two, but THREE contract extensions. SubjectWell onboarded a sciatica study as recruiting began and referrals/randomizations were so reliable that the sponsor opted to extend the contract three times — ultimately delivering 33% of all randomizations. Learn more in this case study: https://lnkd.in/gCiykna5 #lifesciences #clinicalresearch #patientrecruitment

Find qualified patients through hyper-targeted Healthcare Provider outreach. SubjectWell’s Recruitment Agency leverages our HCP Referral Network to find the patients you need — especially for oncology and rare disease studies — by identifying and reaching out to diagnosing doctors through multi-channel digital campaigns. https://lnkd.in/gS2r38mN #hcpreferralprograms #clinicaltrials #patientrecruitment #lifesciences

Our vision at SubjectWell has always been focused on improving global healthcare. Yesterday marked an important milestone in our journey and significantly enhanced our ability to serve patients and customers around the globe. #patientrecruitment #clinicaltrials #patientengagement

We're thrilled to announce that SubjectWell has acquired Trials24! By combining SubjectWell's Patient Network with Trials24's local native language engagement centers in 13 European countries, we'll be able to support the patient journey for any study, including multi-country studies. Data shows that patients trust local speakers who can guide and educate them, leading to faster enrollments and reduced costs for you. Learn more about this exciting step forward: https://lnkd.in/g5pC5a8c

Welcome Suzanne Harris to the SubjectWell Team! We are thrilled to announce that Suzanne Harris has joined SubjectWell as our Senior Vice President of Marketing. Suzanne brings decades of experience in marketing and communications including strategy, positioning, brand development, and demand generation. Her personal experience with clinical trials and patient advocacy gives her a unique and valuable strategic perspective. With a “patient-first” mindset, we are confident Suzanne will impact patients, customers, colleagues, and our business in meaningful and innovative ways.

Attention healthcare marketers! SubjectWell’s BrandConnect already has the patients you need. Come see Nick Elvis and James Rucki at Digital Pharma Series and learn how to access 13 million+ patients motivated to try your treatments. #DPEAST

We have the patients you need! When a top 10 pharmaceutical company needed to recruit patients with the rare Autosomal Dominant Polycystic Kidney Disease (ADPKD), we used multiple concurrent strategies to find and pre-screen hundreds of patients — and met all the key data privacy regulations and certifications across multiple countries. Learn more in this case study: https://lnkd.in/gMsm-UPb #lifesciences #clinicalresearch #patientrecruitment #raredisease #PKDAwarenessDay